Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at IGM Biosciences Inc fell by 8.81m. Cash Flow from Financing totalled 115.07m or 5,402.25% of revenues. In addition the company used 192.23m for operations while cash from investing totalled 68.36m.
Cash flow per share | -3.52 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.07 |
---|---|
Tangible book value per share | 2.07 |
More ▼
Balance sheet in USDView more
Current ratio | 7.06 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼